GCP
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations. (NCT06334510) | Hualan Biological Bacterin Co. Ltd. | 2021-11-17 |
| Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years (NCT06095947) | Hualan Biological Bacterin Co. Ltd. | 2021-09-15 |
Track GCP automatically
Every clearance here is in the API, with alerts when new ones post.